Analytical Data
-
Gene name
FLRT1
- Application
-
Alternative Names
Fibronectin-like domain-containing leucine-rich transmembrane protein 1; Leucine-rich repeat transmembrane protein FLRT1
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
Q6RKD8
-
Expression Region
Ser373~Asn544
-
Molecular Weight
24kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FLRT1 (Fibronectin Leucine-Rich Transmembrane Protein 1) is a member of the FLRT family, known for its role in cell adhesion, migration, and signaling during developmental processes. Research into FLRT1 has gained traction due to its significant involvement in various biological functions, including neuronal development, tissue homeostasis, and the immune response. The protein's structure features multiple leucine-rich repeats, suggesting its potential to interact with other proteins and extracellular matrix components. Dysregulation of FLRT1 has been implicated in several pathological conditions, such as cancer and neurodevelopmental disorders, making it a promising target for therapeutic interventions. The expression patterns of FLRT1 during embryogenesis and its interaction with receptors such as Cdo and Unc5 have highlighted its importance in modulating morphogenetic processes. Moreover, the study of FLRT1 recombinant proteins is crucial in elucidating the mechanisms underlying these interactions and their biological consequences. By constructing and characterizing recombinant FLRT1 proteins, researchers aim to investigate its functional roles in cellular contexts and beyond, paving the way for new insights into FLRT1's contributions to health and disease. Such research not only enhances our understanding of fundamental biological processes but also opens avenues for potential clinical applications in regenerative medicine and targeted therapies.
